Interactions Between Phospholamban and β-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality

Author:

Dash Rajesh1,Kadambi Vivek J.1,Schmidt Albrecht G.1,Tepe Nicole M.1,Biniakiewicz Danuta1,Gerst Michael J.1,Canning Amy M.1,Abraham William T.1,Hoit Brian D.1,Liggett Stephen B.1,Lorenz John N.1,Dorn Gerald W.1,Kranias Evangelia G.1

Affiliation:

1. From the Department of Cardiovascular Biology (V.J.K.), Millennium Pharmaceuticals Inc, Cambridge, Mass; the Department of Medicine (B.D.H.), Case Western Reserve University, Cleveland, Ohio; and the Departments of Pharmacology (R.D., A.G.S., N.M.T., M.J.G., S.B.L., G.W.D., E.G.K.), Physiology (J.N.L., E.G.K.), and Medicine (D.B., A.M.C., W.T.A., S.B.L., G.W.D.), University of Cincinnati College of Medicine, Cincinnati, Ohio.

Abstract

Background —Relieving the inhibition of sarcoplasmic reticular function by phospholamban is a major target of β-adrenergic stimulation. Chronic β-adrenergic receptor activity has been suggested to be detrimental, on the basis of transgenic overexpression of the receptor or its signaling effectors. However, it is not known whether physiological levels of sympathetic tone, in the absence of preexisting heart failure, are similarly detrimental. Methods and Results —Transgenic mice overexpressing phospholamban at 4-fold normal levels were generated, and at 3 months, they exhibited mildly depressed ventricular contractility without heart failure. As expected, transgenic cardiomyocyte mechanics and calcium kinetics were depressed, but isoproterenol reversed the inhibitory effects of phospholamban on these parameters. In vivo cardiac function was substantially depressed by propranolol administration, suggesting enhanced sympathetic tone. Indeed, plasma norepinephrine levels and the phosphorylation status of phospholamban were elevated, reflecting increased adrenergic drive in transgenic hearts. On aging, the chronic enhancement of adrenergic tone was associated with a desensitization of adenylyl cyclase (which intensified the inhibitory effects of phospholamban), the development of overt heart failure, and a premature mortality. Conclusions —The unique interaction between phospholamban and increased adrenergic drive, elucidated herein, provides the first evidence that compensatory increases in catecholamine stimulation can, even in the absence of preexisting heart failure, be a primary causative factor in the development of cardiomyopathy and early mortality.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3